PolyNovo (ASX:PNV) pleased to report Taiwan FDA approval
Latest Company News - Finance News Network
English - October 27, 2020 23:10 - 55 seconds - 1000 KBBusiness News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Market update with Shaw and Partners, October 2020
Next Episode: ANZ (ASX:ANZ) report cash profit down 42%
28 Oct 2020 - PolyNovo (ASX:PNV) has announced the approval of NovoSorb BTM by the Taiwan FDA for sale in Taiwan.